- Home
- SOBR vs SCNI Comparison
SOBR vs SCNI Comparison
Compare SOBR & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOBR
- SCNI
- Stock Information
- Founded
- SOBR 2004
- SCNI 2003
- Country
- SOBR United States
- SCNI Israel
- Employees
- SOBR N/A
- SCNI N/A
- Industry
- SOBR Newspapers/Magazines
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOBR Consumer Discretionary
- SCNI Health Care
- Exchange
- SOBR Nasdaq
- SCNI Nasdaq
- Market Cap
- SOBR 3.7M
- SCNI 3.5M
- IPO Year
- SOBR N/A
- SCNI N/A
- Fundamental
- Price
- SOBR $0.95
- SCNI $3.35
- Analyst Decision
- SOBR
- SCNI
- Analyst Count
- SOBR 0
- SCNI 0
- Target Price
- SOBR N/A
- SCNI N/A
- AVG Volume (30 Days)
- SOBR 2.3M
- SCNI 11.8K
- Earning Date
- SOBR 02-20-2025
- SCNI 11-22-2024
- Dividend Yield
- SOBR N/A
- SCNI N/A
- EPS Growth
- SOBR N/A
- SCNI N/A
- EPS
- SOBR N/A
- SCNI 8.20
- Revenue
- SOBR $183,859.00
- SCNI $452,000.00
- Revenue This Year
- SOBR $2,351.49
- SCNI N/A
- Revenue Next Year
- SOBR N/A
- SCNI N/A
- P/E Ratio
- SOBR N/A
- SCNI $0.41
- Revenue Growth
- SOBR 27.39
- SCNI N/A
- 52 Week Low
- SOBR $0.86
- SCNI $2.23
- 52 Week High
- SOBR $88.00
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- SOBR 22.97
- SCNI 48.74
- Support Level
- SOBR $0.86
- SCNI $3.32
- Resistance Level
- SOBR $2.20
- SCNI $3.50
- Average True Range (ATR)
- SOBR 0.42
- SCNI 0.15
- MACD
- SOBR -0.26
- SCNI 0.00
- Stochastic Oscillator
- SOBR 2.72
- SCNI 41.94
About SOBR SOBR Safe Inc.
Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending SOBRsafe software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.